Print version

pdf Click to download

Search Pub Med

Back
024P Queen Elizabeth II Conference Centre London
BPS Winter Meeting 2009

 

 

 

Fluoxetine and clomipramine inhibit mitochondrial respiration in a murine pancreatic β-cell line

Paul Smith. University of Nottingham, Nottingham, United Kingdom.

 

In man, the use of antidepressants has been associated with both hyperglycaemia (Derijks et al. 2008) and an increased risk of type 2 diabetes (Brown et al. 2008). Since certain antidepressants target mitochondrial function (Souza et al 1994; Eto et al 1985) and as the latter is a key component of the glucose stimulated-insulin secretion pathway, the glycaemic affects of antidepressants may result from a direct action on beta-cell function. I have investigated this possibility by investigating the acute action of antidepressants on mitochondrial function within intact beta-cells.

For this study, the MIN6 beta-cell model cell line was used. Polarographic detection of O2 consumption in cell suspensions was used to measure the rate of respiration (ΔO2) at 37°C. Fluorescence imaging of cells loaded with Rhodamine 123 was used to monitor mitochondrial membrane potential (Δψm) at 32°C.

At 10 μM, the tricyclic antidepressant clomipramine inhibited glucose-stimulated ΔO2 by 12 ± 4 % (n = 20) whereas 100 μM of the drug inhibited ΔO2 by 27 ± 8 % (n = 18). Similar effects were seen with fluoxetine, a selective serotonin reuptake inhibitor; where at 10 μM, fluoxetine inhibited glucose-stimulated ΔO2 by 9.2 ± 2 % (n = 29) and at 100 μM it inhibited ΔO2 by 27 ± 5% (n = 17). These effects were all significantly different (p<0.05) to that of H20, the vehicle control (2.4±0.5%, n = 35; Kruskal-Wallis plus Conover-Inman post hoc test). The hyperpolarization in Δψm produced by 10 mM glucose was decreased by 0.2 ± 0.03 % min-1 (n = 3) with 10 μM fluoxetine and by 2 ± 1% min-1 (n = 3) with 100 μM fluoxetine, but was quenched with 100 μM clomipramine. In conclusion the antidepressants fluoxetine and clomipramine acutely inhibit mitochondrial function in pancreatic beta-cells; the expected corollary is that they will also inhibit insulin secretion.

 

Derijks et al. (2008) Eur. J. Clin. Pharm., 64, 531-538.
Brown et al. (2008) Diab. Res. Clin. Prac. 79, 61–67.
Eto et al. (1985) Acta Med Okayama. 39, 289-295.
Souza et al. (1994) Biochem. Pharm. 48,535-341.